CN Patent

CN107811967B — 抗寄生虫药物原位固化缓释注射剂及其制备方法

Assigned to National Institute of Parasitic Diseases of Chinese Center for Disease Control and Prevention · Expires 2021-08-24 · 5y expired

What this patent protects

本发明公开了一种抗寄生虫药物原位固化缓释注射剂及其制备方法，该制剂包括下述配比的组分：抗寄生虫病药物1‑80g、生物可降解高分子材料1‑100g、分散介质2‑300mL和增溶剂0‑50g；所述抗寄生虫病药物的含量为1‑800mg/mL。该制剂对给药对象只用药1次，即可维持长期防控效果，保护其长时间不受病原感染，可以经济有效地控制寄生虫病传播，材料安全性高，简化了市售抗寄生虫病药物的处方，提高了给药对象依从性，降低防控成本。同时本发明创新性使用WHO的灭螺药‑氯硝柳胺制备皮下注射缓释制剂，达到预防日本血吸虫感染的效果。该抗寄生虫药物原位固化缓释注射剂的制备…

USPTO Abstract

本发明公开了一种抗寄生虫药物原位固化缓释注射剂及其制备方法，该制剂包括下述配比的组分：抗寄生虫病药物1‑80g、生物可降解高分子材料1‑100g、分散介质2‑300mL和增溶剂0‑50g；所述抗寄生虫病药物的含量为1‑800mg/mL。该制剂对给药对象只用药1次，即可维持长期防控效果，保护其长时间不受病原感染，可以经济有效地控制寄生虫病传播，材料安全性高，简化了市售抗寄生虫病药物的处方，提高了给药对象依从性，降低防控成本。同时本发明创新性使用WHO的灭螺药‑氯硝柳胺制备皮下注射缓释制剂，达到预防日本血吸虫感染的效果。该抗寄生虫药物原位固化缓释注射剂的制备方法简单，稳定性好，易于应用和推广。

Drugs covered by this patent

Patent Metadata

Patent number
CN107811967B
Jurisdiction
CN
Classification
—
Expires
2021-08-24
Drug substance claim
No
Drug product claim
No
Assignee
National Institute of Parasitic Diseases of Chinese Center for Disease Control and Prevention
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.